chimeric antigen receptor
Available on Demand
T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.
| 3 min read
Single amino acid changes in healthy hematopoietic stem cells may lead to safer treatments for acute myeloid leukemia.
| 10 min read
Natural killer cells offer safe and effective cancer treatment, but to succeed in the clinic, they need a bit of an energy boost.
Available on Demand
Chimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.
| 6 min read
A team of industry and academic researchers developed a new way to engineer the immune
system, leading to the first clinical trial using genetically modified macrophages.
Available on Demand
Learn how scientists leverage the power of natural killer cells to fight cancer.
Page 1 of 1 - 6 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
